ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
2,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
3,1,Neurodermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
3,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3,3,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
4,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
4,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
5,1,Application site papules,Application site reactions,Administration site reactions,Genrl,N
5,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
6,1,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
6,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
7,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
7,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
7,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
8,1,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
9,1,Administration site inflammation,Administration site reactions NEC,Administration site reactions,Genrl,N
10,1,Ejaculation failure,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
11,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
11,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
11,3,Ejaculation disorder,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
11,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
11,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
11,6,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
12,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
13,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
14,1,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
15,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
16,1,Tongue neoplasm malignant stage unspecified,Lip and oral cavity neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
17,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
18,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
19,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
20,1,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
20,2,Menstruation delayed,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
21,1,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,Y
22,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
23,1,Abdominal sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
24,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
25,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
26,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
26,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
26,3,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
26,4,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
26,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
26,6,Infection susceptibility increased,Infections NEC,Infections - pathogen unspecified,Infec,N
26,7,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
27,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
28,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
28,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
28,3,Feeling of body temperature change,Feelings and sensations NEC,General system disorders NEC,Genrl,N
28,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
28,5,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
29,1,Product design issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
29,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
30,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
30,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
31,1,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
32,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
32,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
33,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
34,1,Uterine cancer,Uterine neoplasms malignant NEC,Reproductive neoplasms female malignant and unspecified,Neopl,N
